Algernon Pharmaceuticals Inc (AGNPF)

[bettingonbayst]

This is the complete outline of the new phase 2b/3 trial to take place in Canada. The start date is set for July 2020 and has an estimated enrollment of 462. This study is to determine the clinical efficacy of Ifenprodil in the treatment of patients infected with COVID-19. It is an International study lead by Algernon with collaboration from Novotec. By the looks of it, this trial itinerary was processed today May 11. This is a news before the official news situation, meaning we should get a posted update from the company very soon. Please read the full itinerary posted on Clinicaltrials.gov. There is a lot of information there and I'm going to re-read again tonight. This is my first time posting on investorshub and I'm excited to discuss stocks in the future with all of you. If anyone is on fintwit, I'm @bettingonbayst. I hold a long position in AGN among others. This is a good speculative play and worth holding for months unless something fundamentally changes. Good luck everyone.

https://trialbulletin.com/lib/entry/ct-04382924